MH

MindWalk Holdings Corp.

HYFT·NASDAQ

$1.82

+6.1%
HealthcareBiotechnology

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

At a Glance

Live Snapshot
Market Cap$84.87M
EPS-0.9100
P/E Ratio-2.00
Earnings Date03/26/2026

hyft

Effect of Foreign Exchange Changes on Cash

Last Annual Value

-438.00K

3-Year CAGR

-25%

5-Year CAGR

-55%

10-Year CAGR

-93%

MH

MindWalk Holdings Corp. Competitors Analysis of Effect of Foreign Exchange Changes on Cash

HYFT · NASDAQ
CompanyEffect of Foreign Exchange Changes on Cash
CAGR 3Y
CAGR 5Y
CAGR 10Y
-438.00K
N/AN/AN/A 
231.00K
42.4%33.2%N/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
0.00
N/AN/AN/A
CLNN logo
Clene Inc.
NASDAQ:CLNN
101.00K
N/AN/AN/A
CRVO logo
CervoMed Inc.
NASDAQ:CRVO
0.00
N/AN/AN/A
0.00
N/AN/AN/A
XBIT logo
XBiotech Inc.
NASDAQ:XBIT
3.33M
N/A36.4%29.2%
IMA logo
ImageneBio Inc
NASDAQ:IMA
604.00K
N/AN/AN/A
MH

MindWalk Holdings Corp. Fair Value Envelope

HYFT · NASDAQ

Our analysis suggests that HYFT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.82, this represents a potential HIDDEN relative to our calculated worth for MindWalk Holdings Corp..

Intrinsic Value
Current Price: $1.82